GHRH Analog Component
Teichman et al., 2006
- Other names
- Mod GRF 1-29, Modified GRF
- Type
- GHRH analog
- Amino Acids
- 29
- Molecular Weight
- ~3,367 g/mol
- Mechanism
- GHRH receptor agonist
- Half-life (No DAC)
- 30 min – 2 hours
Blends
CJC-1295 + Ipamorelin (No DAC)
≥99% purityLyophilized powderThird-party COA
CJC-1295 + Ipamorelin (No DAC) is supplied as a sterile lyophilized powder in a sealed glass vial, manufactured to ≥99% purity. Every batch is verified by independent third-party analysis and ships with a Certificate of Analysis.
$59.99
1
- ✓ Same-day dispatch
- ✓ Discreet packaging
- ✓ Third-party tested batch
- ✓ COA available
Certificate of analysis
The report for the current batch is available on request. Request it here.
CJC-1295 + Ipamorelin (No DAC) is supplied as a sterile lyophilized powder in a sealed glass vial, manufactured to ≥99% purity. Every batch is verified by independent third-party analysis and ships with a Certificate of Analysis.
⚠ Research use only. This product is intended solely for in-vitro laboratory research by qualified professionals. Not for human or veterinary use.
Research overview
About CJC-1295 + Ipamorelin (No DAC)
CJC-1295 + Ipamorelin is a popular research peptide combination (often called a GH stack) designed to synergistically stimulate growth hormone (GH) release from the pituitary gland.
CJC-1295 (with or without DAC) is a long-acting Growth Hormone Releasing Hormone (GHRH) analog that extends the duration of GH pulses. Ipamorelin is a selective Growth Hormone Secretagogue (GHS) that mimics ghrelin, promoting pulsatile GH release with minimal impact on cortisol or prolactin.
When combined, they are studied for amplified, more natural GH secretion patterns compared to either peptide alone.
Key Research Areas
- Growth hormone stimulation and pulsatile release
- Muscle growth, recovery, and body composition
- Fat metabolism and lipolysis
- Anti-aging and longevity models
- Sleep quality and overall recovery
Ipamorelin
Selective GHRP Component
Raun et al.,
- Type
- Growth hormone secretagogue
- Amino Acids
- 5 (pentapeptide)
- Molecular Weight
- 711.85 g/mol
- Sequence
- Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Mechanism
- Ghrelin receptor (GHSR-1a) agonist
- Selectivity
- no cortisol/prolactin elevation
Sources & references6 peer-reviewed publications and databases
Journal of Clinical Endocrinology & Metabolism
Teichman SL, Neale A, Lawrence B et al.
2006 · DOI: 10.1210/jc.2005-1702 · PMID: 16352683
European Journal of Endocrinology
Ipamorelin, the first selective growth hormone secretagogue
Raun K, Hansen BS, Johansen NL et al.
1998 · DOI: 10.1530/eje.0.1390552 · PMID: 9849822
Journal of Clinical Endocrinology & Metabolism
On the actions of the growth hormone-releasing hexapeptide, GHRP
Bowers CY, Reynolds GA, Durham D et al.
1991 · PMID: 1919399
Translational Andrology and Urology
A Review of Growth Hormone Secretagogues
Sigalos JT, Pastuszak AW
2018 · DOI: 10.21037/tau.2018.06.09 · PMID: 30186644
Journal of Clinical Endocrinology & Metabolism
Effects of Growth Hormone and Its Secretagogues on Bone
Svensson J, Ohlsson C, Jansson JO et al.
1998 · PMID: 9851737
Journal of Clinical Endocrinology & Metabolism
Alba M, Fintini D, Sagazio A et al.
2006 · DOI: 10.1210/jc.2005-2371 · PMID: 16670169
Research summaries and references are drawn from published, peer-reviewed literature and are provided for educational reference only. They are not product claims or medical advice. This product is sold strictly for laboratory research and is not for human or veterinary use.
Related research
